Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan vs Valsartan in Mild to Moderate Essential Hypertension
NCT02495324Phase 4Completed
- Sponsor
- Boryung
- Start
- Jun 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fimasartan in essential hypertension, sponsored by Boryung. Started Jun 2015; status: completed.
02
Drugs
fimasartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02495324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02495324.